Magnesium — Research Evidence

The research on magnesium supplementation spans a wide range of health outcomes, including sleep, metabolic health, cardiovascular function, cognitive performance, bone health, muscle function, and migraine prevention. Across the 15 sources reviewed — including multiple meta-analyses and systematic reviews — magnesium shows the most consistent evidence in areas related to glucose metabolism, sleep quality in older adults, and migraine prophylaxis. However, the breadth of claims made about magnesium in popular health discourse far outpaces what the current evidence can firmly support, with the vast majority of expert claims (over 80%) rated as having insufficient evidence based on this literature.

The strongest signals come from meta-analyses and systematic reviews of randomized controlled trials. A strong-quality meta-analysis on oral magnesium supplementation for insomnia in older adults found improvements in sleep-related outcomes, lending partial support to claims about magnesium's role in sleep quality, particularly depth of sleep and sleep onset. A strong-quality meta-analysis on glucose metabolism found that magnesium supplementation may improve parameters in people with or at risk of diabetes. Moderate-quality reviews suggest a plausible role for magnesium in migraine prevention, cardiovascular health, and reducing symptoms associated with obesity and metabolic syndrome. Evidence on muscle soreness, cognitive health, and skeletal health comes from systematic reviews of varying quality, with generally cautious but modestly positive conclusions. Notably, a systematic review on bioavailability found meaningful differences between magnesium forms, which matters for interpreting results across studies that use different compounds.

Several important limitations temper these findings. Many of the underlying studies in these reviews involve older adults, people with diagnosed deficiency, or clinical populations — making it unclear how well results generalize to healthy, replete individuals, which is the primary target audience for most supplement use. The metadata for most sources in this review lacked specific sample sizes and granular key findings, limiting the precision of this summary. Form-specific evidence (e.g., glycinate vs. threonate vs. malate) remains sparse in high-quality trials, making it difficult to validate specific form recommendations despite their widespread popularity. Additionally, the overwhelming proportion of expert claims (252 of 313) were rated as having insufficient evidence, underscoring a large gap between what is commonly claimed and what the research currently supports.

Studies (21)